Top Stories (Grainnet.com)
Arlington, VA The Food & Drug Administration s (FDA) foresight in recognizing the importance of professional industry third-party certification programs as a powerful tool to assist industry compliance with FDA rules and regulations was praised this week by the American Feed Industry Association (AFIA), which formally notified the agency last week of its strong support for the initiative.

FDA Accepts Immucor's Response to Warning Letter (PR Newswire via Yahoo! Finance)
Immucor, Inc., , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced that today the FDA notified the company that it has reviewed Immucor's response to the previously-reported warning letter, and Immucor's proposed corrective actions appear to be adequate.

Amgen And Wyeth Statement On The FDA Early Communication About Tumor Necrosis Factor (TNF) Blockers (Medical News Today)
Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), issued a statement in response to the Food and Drug Administration (FDA) Early Communication regarding an ongoing safety review of Tumor Necrosis Factor (TNF) blockers (marketed as Remicade, Enbrel, Humira and Cimzia) an